Skip to content

Total debt at other companies

IAR
Integra LifeSciencesIART
$1.98B+3.2%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$70.46M-3.7%
AngioDynamics logo
AngioDynamicsANGO
$7.9M+10.2%
Abbott logo
AbbottABT
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Calculated from ClearPoint Neuro’s reported figures.

Plus components not separately reported this period.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's total debt?
ClearPoint Neuro (CLPT) reported total debt of $63.59M in Q1 2026.
How has ClearPoint Neuro's total debt changed year-over-year?
ClearPoint Neuro's total debt increased by 1749.6% year-over-year, from $3.44M to $63.59M.
What is the long-term trend for ClearPoint Neuro's total debt?
Over 5 years (2020 to 2025), ClearPoint Neuro's total debt has grown at a 19.2% compound annual growth rate (CAGR), from $24.24M to $58.23M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.